1<p>According to SCAN-interview (Giel and Nienhuis, 1996) <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0113521#pone.0113521-Giel1" target="_blank">[42]</a>.</p>2<p>1 = severe dysfunction, 100 = optimal functioning.</p>3<p>Categorized according to Herrmann et al. (1998) <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0113521#pone.0113521-Hermann1" target="_blank">[59]</a>.</p>4<p>According to Andreassen et al., 2010 <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0113521#pone.0113521-Andreasen1" target="_blank">[60]</a>.</p><p>Clinical characteristics of participants in PROGR-S.</p
<p>Characteristics of the Study Cohort<sup><a href="http://www.plosone.org/article/info:doi/10.1371/...
<p>*Selected specificity cutoff for each cohort based on PPV> = 90%; RA based on medical record revi...
<p>Characteristics of POAG patients and control subjects included in this study.</p
1<p>According to Verhage, 1984 <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone...
<p>Sociodemographic and clinical characteristics of the participants [<a href="http://www.plosone.or...
<p>Baseline characteristics of included patients in the study (110449 patients)<sup><a href="http://...
<p>See also [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0135545#pone.0135...
<p>Note: Characteristics are reported as percentages for categorical variables and means (±SD) or me...
<p>Demographic and basic clinical characteristics of the study population.<a href="http://www.ploson...
Clinical characteristics of probands who underwent genetic testing (N = 460).</p
<p>Characteristics of study participants (n = 414) and comparison between PMS cases (n = 80) and con...
<p>Characteristics of the study participants<sup><a href="http://www.plosone.org/article/info:doi/10...
<p>Baseline characteristics of the patients<sup><a href="http://www.plosone.org/article/info:doi/10....
<p>ER, estrogen receptor; PR, progesterone receptor</p><p><sup>1</sup>Not all patients had informati...
<p>Unless otherwise indicated, values are mean (standard deviation). SIPS (Structured Interview for ...
<p>Characteristics of the Study Cohort<sup><a href="http://www.plosone.org/article/info:doi/10.1371/...
<p>*Selected specificity cutoff for each cohort based on PPV> = 90%; RA based on medical record revi...
<p>Characteristics of POAG patients and control subjects included in this study.</p
1<p>According to Verhage, 1984 <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone...
<p>Sociodemographic and clinical characteristics of the participants [<a href="http://www.plosone.or...
<p>Baseline characteristics of included patients in the study (110449 patients)<sup><a href="http://...
<p>See also [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0135545#pone.0135...
<p>Note: Characteristics are reported as percentages for categorical variables and means (±SD) or me...
<p>Demographic and basic clinical characteristics of the study population.<a href="http://www.ploson...
Clinical characteristics of probands who underwent genetic testing (N = 460).</p
<p>Characteristics of study participants (n = 414) and comparison between PMS cases (n = 80) and con...
<p>Characteristics of the study participants<sup><a href="http://www.plosone.org/article/info:doi/10...
<p>Baseline characteristics of the patients<sup><a href="http://www.plosone.org/article/info:doi/10....
<p>ER, estrogen receptor; PR, progesterone receptor</p><p><sup>1</sup>Not all patients had informati...
<p>Unless otherwise indicated, values are mean (standard deviation). SIPS (Structured Interview for ...
<p>Characteristics of the Study Cohort<sup><a href="http://www.plosone.org/article/info:doi/10.1371/...
<p>*Selected specificity cutoff for each cohort based on PPV> = 90%; RA based on medical record revi...
<p>Characteristics of POAG patients and control subjects included in this study.</p